Sydney Lupkin
Stories
-
Why a new opioid alternative is out of reach for some pain patients
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
-
A new painkiller is providing an alternative to opioids, but many people can't get it
The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.
-
4 things to know about the vaccine ingredient thimerosal
Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal. Why is the additive, safely used since the 1930s, being questioned again?
-
A new chapter for online sales of obesity drug alternatives tests legal limits
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.
-
Online sales of obesity drug alternatives carry on despite FDA deadlines
Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.
-
Medicare negotiations underway to lower prices for next batch of drugs
In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.
-
Trump signs executive order to reduce prescription drug prices
President Trump's latest executive order on drug prices aims to lower them by bringing them into line with what other developed countries pay. Experts caution that this is no small task.
-
Trump signs an order to reduce drug prices, but it's unclear how it would work
President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.
-
House oversight committee demands answers on gutting of CDC public records office
House Rep. Gerry Connolly is pushing CDC leadership to explain why the personnel who handle FOIA requests lost their jobs, noting that that the public has a right to access federal records.
-
Eli Lilly sues companies selling alternative versions of its weight loss drug
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.